Ceri M. Wiggins

576 total citations
12 papers, 492 citations indexed

About

Ceri M. Wiggins is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ceri M. Wiggins has authored 12 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Ceri M. Wiggins's work include Cell death mechanisms and regulation (5 papers), CRISPR and Genetic Engineering (3 papers) and Ubiquitin and proteasome pathways (3 papers). Ceri M. Wiggins is often cited by papers focused on Cell death mechanisms and regulation (5 papers), CRISPR and Genetic Engineering (3 papers) and Ubiquitin and proteasome pathways (3 papers). Ceri M. Wiggins collaborates with scholars based in United Kingdom, United States and Australia. Ceri M. Wiggins's co-authors include Simon J. Cook, Katherine Ewings, Kathryn Balmanno, Mark Johnson, Kurt Degenhardt, Julie A. Wickenden, Eileen White, Rebecca Gilley, Hamid Band and David Komander and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Cancer Research.

In The Last Decade

Ceri M. Wiggins

10 papers receiving 487 citations

Peers

Ceri M. Wiggins
Angen Liu United States
Sarah A Molton United States
Joanne M. Munck United Kingdom
Amy M. Delaney United States
Su‐Fern Tan United States
Angen Liu United States
Ceri M. Wiggins
Citations per year, relative to Ceri M. Wiggins Ceri M. Wiggins (= 1×) peers Angen Liu

Countries citing papers authored by Ceri M. Wiggins

Since Specialization
Citations

This map shows the geographic impact of Ceri M. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ceri M. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ceri M. Wiggins more than expected).

Fields of papers citing papers by Ceri M. Wiggins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ceri M. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ceri M. Wiggins. The network helps show where Ceri M. Wiggins may publish in the future.

Co-authorship network of co-authors of Ceri M. Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Ceri M. Wiggins. A scholar is included among the top collaborators of Ceri M. Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ceri M. Wiggins. Ceri M. Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Leong, Hui Sun, Tianhui Zhang, Adam Corrigan, et al.. (2024). Hit screening with multivariate robust outlier detection. PLoS ONE. 19(9). e0310433–e0310433.
3.
Tan, Victor M., Jingjing Guo, Hanlin Tao, et al.. (2021). Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System. The CRISPR Journal. 4(1). 58–68. 9 indexed citations
4.
Cairney, Claire J., Alan Bilsland, Sharon Burns, et al.. (2017). A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds. PLoS Genetics. 13(8). e1006942–e1006942. 10 indexed citations
5.
Haagensen, Emma J., Huw D. Thomas, Ceri M. Wiggins, et al.. (2016). Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent. European Journal of Cancer. 56. 69–76. 12 indexed citations
6.
Foster, Rebecca R., et al.. (2013). Abstract 4289: 3-Dimensional growth reveals KRAS dependency.. Cancer Research. 73(8_Supplement). 4289–4289. 2 indexed citations
7.
Wiggins, Ceri M., Peter Tsvetkov, Mark Johnson, et al.. (2011). BIMEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. Journal of Cell Science. 124(6). 969–977. 62 indexed citations
8.
Wiggins, Ceri M., Mark Johnson, & Simon J. Cook. (2010). Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM. Cellular Signalling. 22(5). 801–808. 9 indexed citations
9.
Balmanno, Kathryn, et al.. (2009). Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene‐targeted therapeutics. FEBS Journal. 276(21). 6050–6062. 91 indexed citations
10.
Wiggins, Ceri M., Hamid Band, & Simon J. Cook. (2007). c-Cbl is not required for ERK1/2-dependent degradation of BimEL. Cellular Signalling. 19(12). 2605–2611. 24 indexed citations
11.
Ewings, Katherine, Ceri M. Wiggins, & Simon J. Cook. (2007). Bim and the Pro-Survival Bcl-2 Proteins: Opposites Attract, ERK Repels. Cell Cycle. 6(18). 2236–2240. 128 indexed citations
12.
Ewings, Katherine, Ceri M. Wiggins, Julie A. Wickenden, et al.. (2007). ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL. The EMBO Journal. 26(12). 2856–2867. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026